Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer
Triple-negative breast cancer (TNBC), which is the most malignant subtype of breast cancer (BC), accounts for 10%-20% of all BC cases. TNBC, which occurs more frequently in young women, is characterized by high rates of cell proliferation and metastasis and poor prognosis. Chemotherapy is the primar...
Saved in:
Main Authors: | Tian Tian (Author), Yangzhi Zhao (Author), Jingying Zheng (Author), Shunzi Jin (Author), Zhongshan Liu (Author), Tiejun Wang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AFF3 is a Prognostic Biomarker Correlated with Immune Infiltrates in Triple-Negative Breast Cancer
by: Jing Chen, et al.
Published: (2023) -
Clinical, histomorphological, and therapeutic prognostic factors in patients with triple-negative invasive breast cancer
by: Camila M. Lopes, et al.
Published: (2015) -
ARNTL2 is a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Triple-Negative Breast Cancer
by: Wang X, et al.
Published: (2021) -
Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
by: Yuxiang Lin, et al.
Published: (2022) -
RNA-Based Therapeutics: Current Developments in Targeted Molecular Therapy of Triple-Negative Breast Cancer
by: Sakib Haque, et al.
Published: (2021)